Mylan Wins Bid To Block Apotex's Generic Paxil

Law360, New York (September 21, 2010, 12:10 PM EDT) -- Mylan Inc. won an order Tuesday barring Apotex Inc. from making a generic form of GlaxoSmithKline PLC's Paxil, in a suit that accuses the brand-name drugmaker and Apotex of seeking to put out a rival copycat version of the anti-depressant in breach of an exclusivity agreement.

Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey enjoined Apotex from manufacturing or marketing the drug until an Oct. 18 hearing on the matter.

Mylan filed suit Monday, claiming the sole right to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.